losartan and ramipril

losartan has been researched along with ramipril in 105 studies

Research

Studies (105)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	29 (27.62)	18.2507
2000's	46 (43.81)	29.6817
2010's	29 (27.62)	24.3611
2020's	1 (0.95)	2.80

Authors

Authors	Studies
Abbenante, G; Fairlie, DP; Leung, D	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Barton, P; Luker, T; Wenlock, MC	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Carretero, OA; Farhy, RD; Ho, KL; Scicli, AG	1
Cachofeiro, V; Nasjletti, A; Sakakibara, T	1
Henning, R; Linz, W; Schölkens, BA	1
Mohabir, R; Strosberg, AM; Young, SD	1
Hartman, JC	1
Cachofeiro, V; Lahera, V; Maeso, R; Navarro, J; Rodrigo, E; Ruilope, LM	1
Hamann, M; Hegyi, I; Kaissling, B; Kurtz, A; Schricker, K	1
Bader, B; Braun, N; Erley, CM; Risler, T; Scheu, M; Wolf, S	1
Chen, C; Lokhandwala, MF; Sakamoto, T	1
Chen, K; Zimmerman, BG	1
Brasch, H; Dominiak, P; Sieroslawski, L	1
Chatterjee, K; Ives, HE; Sudhir, K; Wilson, E	1
Hartman, JC; Hullinger, TG; Shebuski, RJ; Wall, TM	1
Barthelmebs, M; Grima, M; Imbs, JL	1
Cachofeiro, V; Guan, H; Kaminski, PM; Nasjletti, A; Pucci, ML; Wolin, MS	1
Hérizi, A; Jover, B; Mimran, A	1
DiPette, DJ; Wang, DH; Yao, A; Zhao, H	1
Campagnole-Santos, MJ; Fontes, MA; Khosla, MC; Lima, DX; Oliveira, RC; Santos, RA	1
Dunham, EW; Zhang, X; Zimmerman, BG	1
Dixon, IM; Jassal, DS; Ju, H; Peterson, DJ	1
Amann, K; Gohlke, P; Kuwer, I; Mall, G; Schnell, A; Unger, T	1
Camargo, LA; Fóglia, S; Luiz, AC; Menani, JV; Saad, WA; Silveira, JE	1
Berkenboom, G; Carpentier, Y; Fontaine, J; Grosfils, K; Langer, I	1
Fernández, A; Hortal, L; Lorenzo, M; Losada, A; Palop, L; Plaza, C; Rodríguez, JC; Vega, N	1
Bischoff, A; Michel, MC; Rascher, W	1
Kurtz, A; Wagner, C	1
Friberg, P; Isgaard, J; Wåhlander, H; Wickman, A	1
Elsner, D; Muders, F; Palkovits, M; Riegger, GA; Schunkert, H	1
Baldassarre, S; Berkenboom, G; Fontaine, D; Fontaine, J; Preumont, N; Unger, P	1
Deutsch, P; Ianosi-Irimie, M	1
Amorena, C; Damasco, C; Igarreta, P; MacLaughlin, M	1
Ahlersmann, D; Christoph, A; Drexler, H; Hornig, B; Kohler, C; Landmesser, U; Spiekermann, S; Tatge, H	1
Johnson, RJ; Lombardi, DM; Saavedra, JM; Schwartz, SM; Vio, CP; Viswanathan, M	1
Kramer, CM; Lee, S; Mankad, S; Sandberg, K; Yoo, SE	1
d'Amato, TA; Kramer, CM; Lin, J; Mankad, S; McGregor, WE; Reichek, N; Rogers, WJ; Singh, D	1
Schuitheiss, HP; Tschöpe, C; Walther, T	1
Adam, A; Gagnon, C; Gosselin, H; Kapuku, G; Lambert, C; Meloche, S; Pelletier, S; Rouleau, JL	1
Emanueli, C; Gaspa, L; Maddeddu, P; Madeddu, P; Pinna, A; Salis, MB; Stacca, T	1
Studney, D	1
Mourad, JJ; O'Rourke, MF; Safar, ME	1
Brown, NJ; Kumar, S; Painter, CA; Vaughan, DE	1
Weder, AB	1
Hornig, B	1
Giacca, A; Lapointe, N; Leung, N; Lewis, GF; Rouleau, JL; Szeto, L; Uffelman, KD; Wang, CH	1
Bottoms, SE; Chambers, RC; Gohlke, P; Howell, DC; Laurent, GJ; Marshall, RP; McAnulty, RJ; Unger, T	1
Bishop, SP; Gerdes, AM; Kim, SJ; Kim, YK; Kramer, CM; Mankad, S; Takagi, G; Tamura, T	1
Ge, ZM; Li, XC; Xu, R; Zhang, M; Zhang, W; Zhang, Y	1
Avila-Casado, Mdel C; Bautista, R; Escalante, B; Manning, R; Martinez, F; Medina, A; Soto, V	1
Brainin, M; Finsterer, J; Slany, J; Stöllberger, C	1
Aviram, M; Coleman, R; Hamoud, S; Hayek, T; Kaplan, M; Keidar, S; Pavlotzky, E	1
Kazdova, L; Komers, R; Pelikanova, T; Ruzickova, J; Simkova, R	1
Iwasaka, T; Okigaki, M	1
Bakris, GL; Demopoulos, LA; Fox, JC; Gleim, GW; Leight, K; Lewin, AJ; Sutradhar, SC	1
Avila-Casado, MC; Bautista, R; Coronel, I; Escalante, B; Romo, E; Soto, V; Vázquez, E; Villalón, CM	1
Daniel, WG; Eskafi, S; Gabler, C; Garlichs, CD; Illmer, T; Lorenz, HM; Roerick, O; Schmeisser, A; Soehnlein, O; Strasser, R	1
Chopda, M; Giri, J; Gujarathi, S; Joshi, SR; Maity, A; Maity, AK; Maroli, S; Tripathi, KK; Yeolekar, ME	1
Cornelissen, G; Halberg, F; Otsuka, K; Singh, RB	1
Argano, C; Corrao, S; Di Chiara, T; Licata, A; Licata, G; Scaglione, R	1
Adani, GL; Baccarani, U; Boscutti, G; Bresadola, F; Gropuzzo, M; Mioni, G; Mioni, R; Montanaro, D; Risaliti, A; Sainz, M; Tulissi, P; Vallone, C	1
Cheung, WY; Gibson, IW; Jeffery, J; Karpinski, M; Rush, D	1
Gottsäter, A; Ohlin, AK; Ohlin, H; Tingberg, E	1
Cai, H; Chen, WQ; Ge, ZM; Li, XC; Xu, R; Zhang, M; Zhang, W; Zhang, Y; Zhu, H	1
Chan, TM; Lai, KN; Li, FK; Tang, CS; Tang, S; Tse, KC	1
Chen, P; Dahl, D; Edwards, PA; Fenstermacher, JD; Guo, M; Scicli, AG; Scicli, GM	1
Cai, W; Chen, JZ; Ruan, LM; Wang, YN	1
Coelho, EB; da Silva, CA; Fazan, R; Nobre, F; Salgado, HC	1
Argano, C; Avellone, G; Colomba, D; Corrao, S; Di Chiara, T; Donatelli, M; Licata, G; Parrinello, G; Scaglione, R	1
Akdag, I; Arabul, M; Dilek, K; Ersoy, A; Gullulu, M; Kahvecioglu, S; Yavuz, M; Yurtkuran, M	1
Boada, J; Buleon, M; Girolami, JP; Gonzalo, H; Jové, M; Linz, W; Pamplona, R; Portero-Otín, M; Schäfer, S; Tack, I	1
Nayak, V; Patil, PA	1
Balduini, CL; Fiore, CE; Granata, A; Pecci, A	1
Kamal, Z; Molden, E; Nordstad, MG	1
Dusek, L; Pavlík, T; Soucek, M; Spinar, J; Vítovec, J	1
Neldam, S	1
Bieri, M; Farkas, A; Ligeti, N; Marti, HP; Meier, B; Mohacsi, P; Oroszlán, M	1
Gorski, JC; Lindamood, C; Ortiz, S; Rackley, R; Shaw, A	1
Gaikwad, J; Gupta, A; Khaira, A; Rana, DS	1
Kaynar, K; Kiriş, A; Koşucu, P; Orem, C; Ozkan, G; Ulusoy, S	1
Bilo, G; Mancia, G; Parati, G; Schumacher, H	1
Chung, IM; Kim, CK; Kim, YM; Shin, MK; Suh, SH; Yoo, MH	1
Cicero, AF; D'Angelo, A; Derosa, G; Ferrari, I; Fogari, E; Maffioli, P; Palumbo, I; Randazzo, S	1
Kobayashi, J; Mabuchi, H; Noguchi, T; Nohara, A	1
Circelli, M; Cremonesi, G; Fogari, R; Mugellini, A	1
Caglioti, C; Casoria, V; Comi, N; Conte, G; Fuiano, G; Fuiano, L; Iodice, C; Minutolo, R; Presta, P	1
Bayat, G; Foadoddini, M; Hajizadeh, S; Khoshbaten, A; Safari, F; Shekarforoush, S	1
Amann, K; Kemper, MJ; Lama, A; Lehnhardt, A; Matejas, V; Zenker, M	1
Anvari, Z; Bayat, G; Hajizadeh, S; Hekmatimoghaddam, S; Moghadam, MF; Safari, F; Shekarforoush, S	1
Chazova, IE; Martyniuk, TV	1
Creazzo, M; Dalbeni, A; Dattilo, G; Imbalzano, E; Lizio, G; Mandraffino, G; Saitta, A; Sardo, MA; Scarpelli, M; Tomasello, C; Trapani, G	1
Chang, CH; Lai, MS; Lee, YC; Lin, JW; Lin, MS; Ruan, SY; Wu, LC	1
Chien, WC; Chung, CH; Hsing, SC; Kao, SY; Lu, KC; Sun, CA	1
Dalsing, MC; DiStasi, MR; Miller, SJ; Unthank, JL; Ziegler, MA	1
Buszewicz, G; Celinski, K; Ciesielka, M; Czechowska, G; Kazmierak, W; Kurzepa, J; Madro, A; Madro, R; Slomka, M	1
Marinšek, M; Sinkovič, A	1
Kumar, A; Mourya, A; Sah, SP; Singh, B	1
Dai, Y; Li, G; Li, J; Xu, R; Xu, X; Yao, Y; Yun, L; Zheng, F	1
Balogh, DB; Fekete, A; Genovese, F; Hodrea, J; Hosszu, A; Koszegi, S; Lakat, T; Lenart, L; Molnar, A; Sparding, N; Szabo, AJ; Szkibinszkij, E; Vannay, A; Wagner, L	1
Ababei, DC; Bild, V; Bild, W; Ciobică, A; Lefter, RM; Rusu, RN	1
Chen, CY; Fang, QQ; Hu, YY; Ma, L; Shi, BH; Shi, P; Tan, WQ; Wang, XF; Zhang, LY; Zhang, MX; Zhao, WY; Zheng, B	1
Aiglova, R; Cernicek, V; Danek, J; Gloger, V; Lazarova, M; Pavlu, L; Precek, J; Schee, A; Skala, T; Taborsky, M; Vicha, M	1

Reviews

8 review(s) available for losartan and ramipril

Article	Year
Protease inhibitors: current status and future prospects. Journal of medicinal chemistry, 2000, Feb-10, Volume: 43, Issue:3 Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors	2000
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Angiotensin blockade in type 2 diabetes: what the new evidence tells us about renal and cardiac complications. The Canadian journal of cardiology, 2002, Volume: 18 Suppl A Topics: Albuminuria; Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Humans; Irbesartan; Kidney Diseases; Losartan; Prognosis; Ramipril; Tetrazoles	2002
Vitamins, antioxidants and endothelial function in coronary artery disease. Cardiovascular drugs and therapy, 2002, Volume: 16, Issue:5 Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Ascorbic Acid; Coronary Disease; Endothelium, Vascular; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Losartan; Nitric Oxide; Oxidative Stress; Ramipril; Receptor, Angiotensin, Type 1; Superoxide Dismutase; Vitamins	2002
[Involvement of angiotensin II in pathogenesis of hypertension and target organ damage]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 3 Topics: Angioplasty, Balloon, Coronary; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteriosclerosis; Cardiomegaly; Clinical Trials as Topic; Coronary Restenosis; Humans; Hypertension; Hypertension, Renal; Insulin Resistance; Losartan; Ramipril; Receptor, Angiotensin, Type 1	2004
Choosing an angiotensin-receptor blocker: blood pressure lowering, cardiovascular protection or both? Future cardiology, 2010, Volume: 6, Issue:1 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Cardiovascular Diseases; Humans; Hypertension; Losartan; Ramipril; Risk Factors; Telmisartan; Tetrazoles	2010
Evaluating 24-h antihypertensive efficacy by the smoothness index: a meta-analysis of an ambulatory blood pressure monitoring database. Journal of hypertension, 2010, Volume: 28, Issue:11 Topics: Amlodipine; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Databases, Factual; Female; Humans; Losartan; Male; Ramipril; Randomized Controlled Trials as Topic; Telmisartan; Tetrazoles; Treatment Outcome; Valine; Valsartan	2010
Combination delapril/manidipine as antihypertensive therapy in high-risk patients. Clinical drug investigation, 2011, Volume: 31, Issue:7 Topics: Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Clinical Trials as Topic; Diabetes Complications; Dihydropyridines; Drug Combinations; Enalapril; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Indans; Irbesartan; Losartan; Nitrobenzenes; Obesity; Olmesartan Medoxomil; Piperazines; Ramipril; Tetrazoles; Valine; Valsartan	2011

Trials

21 trial(s) available for losartan and ramipril

Article	Year
Renal hemodynamics in essential hypertensives treated with losartan. Clinical nephrology, 1995, Volume: 43 Suppl 1 Topics: Antihypertensive Agents; Biphenyl Compounds; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Imidazoles; Kidney; Losartan; Male; Middle Aged; Ramipril; Renal Circulation; Renin-Angiotensin System; Tetrazoles	1995
Effect of ramipril and losartan on collagen expression in right and left heart after myocardial infarction. Molecular and cellular biochemistry, 1996, Dec-06, Volume: 165, Issue:1 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Arrhythmia Agents; Biphenyl Compounds; Blotting, Northern; Collagen; Collagenases; Extracellular Matrix; Gene Expression Regulation; Imidazoles; Immunohistochemistry; Losartan; Male; Metalloendopeptidases; Myocardial Infarction; Myocardium; Ramipril; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tetrazoles; Transcription, Genetic; Ventricular Function, Right; Wound Healing	1996
Losartan versus ramipril in the treatment of postrenal transplant erythrocytosis. Transplantation proceedings, 1998, Volume: 30, Issue:5 Topics: Angiotensin-Converting Enzyme Inhibitors; Erythrocyte Count; Erythropoietin; Hematocrit; Humans; Kidney Transplantation; Losartan; Polycythemia; Postoperative Complications; Ramipril; Reticulocyte Count; Transferrin	1998
Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase. Circulation, 2001, Feb-13, Volume: 103, Issue:6 Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Ascorbic Acid; Biological Availability; Coronary Disease; Endothelium, Vascular; Enzyme Activation; Humans; Losartan; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Oxidative Stress; Radial Artery; Ramipril; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Regional Blood Flow; Superoxide Dismutase; Time Factors; Vasodilation	2001
ACE inhibition versus angiotensin type 1 receptor antagonism: differential effects on PAI-1 over time. Hypertension (Dallas, Tex. : 1979), 2002, Volume: 40, Issue:6 Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Blood Pressure; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Insulin; Insulin Resistance; Losartan; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Ramipril; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Sodium Chloride Symporter Inhibitors; Tissue Plasminogen Activator; Treatment Outcome	2002
[Relationship between regression of hypertensive left ventricular hypertrophy and improvement of coronary flow reserve]. Zhonghua yi xue za zhi, 2003, Apr-25, Volume: 83, Issue:8 Topics: Adult; Aged; Coronary Circulation; Echocardiography, Three-Dimensional; Echocardiography, Transesophageal; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Male; Middle Aged; Ramipril	2003
Effects of ACE inhibition and AT1-receptor blockade on haemodynamic responses to L-arginine in Type 1 diabetes. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2004, Volume: 5, Issue:1 Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Arginine; Blood Pressure; Citrulline; Cross-Over Studies; Diabetes Mellitus, Type 1; Drug Synergism; Hemodynamics; Hormones; Humans; Kidney; Losartan; Male; Nitric Oxide; Ramipril	2004
The JNC 7 approach compared to conventional treatment in diabetic patients with hypertension: a double-blind trial of initial monotherapy vs. combination therapy. Journal of clinical hypertension (Greenwich, Conn.), 2004, Volume: 6, Issue:8 Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Chi-Square Distribution; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Ramipril; Treatment Outcome	2004
Evaluation of efficacy and tolerability of Losartan and Ramipril combination in the management of hypertensive patients with associated diabetes mellitus in India (LORD Trial). The Journal of the Association of Physicians of India, 2004, Volume: 52 Topics: Albuminuria; Antihypertensive Agents; Blood Pressure; Comorbidity; Diabetic Angiopathies; Drug Combinations; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Ramipril; Treatment Outcome	2004
Transforming growth factor beta1 and additional renoprotective effect of combination ACE inhibitor and angiotensin II receptor blocker in hypertensive subjects with minor renal abnormalities: a 24-week randomized controlled trial. Journal of hypertension, 2005, Volume: 23, Issue:3 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Drug Therapy, Combination; Female; Humans; Hypertension, Renal; Kidney; Losartan; Male; Middle Aged; Ramipril; Renal Insufficiency; Severity of Illness Index; Transforming Growth Factor beta; Transforming Growth Factor beta1	2005
Renoprotective effect of early inhibition of the renin-angiotensin system in renal transplant recipients. Transplantation proceedings, 2005, Volume: 37, Issue:2 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Creatinine; Enalapril; Follow-Up Studies; Humans; Hypertension; Kidney Function Tests; Kidney Transplantation; Losartan; Proteinuria; Ramipril; Renal Artery; Renin-Angiotensin System; Tetrazoles; Time Factors; Valine; Valsartan	2005
Lipid peroxidation is not increased in heart failure patients on modern pharmacological therapy. International journal of cardiology, 2006, Oct-10, Volume: 112, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Captopril; Comorbidity; Delayed-Action Preparations; Dinoprost; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Lipid Peroxidation; Losartan; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Nitric Oxide Donors; Oxidative Stress; Ramipril; Stroke Volume; Ultrasonography; Ventricular Dysfunction, Left	2006
Effect of dual blockade of renin-angiotensin system on TGFbeta1 and left ventricular structure and function in hypertensive patients. Journal of human hypertension, 2007, Volume: 21, Issue:4 Topics: Adult; Analysis of Variance; Antihypertensive Agents; Biomarkers; Blood Pressure; Collagen Type I; Collagen Type III; Double-Blind Method; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Italy; Losartan; Male; Middle Aged; Prevalence; Ramipril; Renin-Angiotensin System; Severity of Illness Index; Transforming Growth Factor beta1; Treatment Outcome; Ultrasonography; Ventricular Function, Left	2007
Comparison of higher dose of losartan treatment with losartan plus carvedilol and losartan plus ramipril in patients with glomerulonephritis and proteinuria. Renal failure, 2007, Volume: 29, Issue:2 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Carbazoles; Carvedilol; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Glomerulonephritis; Humans; Losartan; Propanolamines; Proteinuria; Ramipril; Treatment Outcome; Vasodilator Agents	2007
CORD: COmparsion of Recommended Doses of ACE inhibitors and angiotensin II receptor blockers. Vnitrni lekarstvi, 2009, Volume: 55, Issue:5 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Ramipril	2009
A comparison of the effects of ramipril and losartan on blood pressure control and left ventricle hypertrophy in patients with autosomal dominant polycystic kidney disease. Renal failure, 2010, Volume: 32, Issue:8 Topics: Adolescent; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Male; Middle Aged; Polycystic Kidney, Autosomal Dominant; Ramipril; Young Adult	2010
Different actions of losartan and ramipril on adipose tissue activity and vascular remodeling biomarkers in hypertensive patients. Hypertension research : official journal of the Japanese Society of Hypertension, 2011, Volume: 34, Issue:1 Topics: Adipose Tissue; Adult; Antihypertensive Agents; Biomarkers; Blood Glucose; Blood Pressure; Body Mass Index; Body Weight; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Female; Glucose Clamp Technique; Humans; Hypertension; Intention to Treat Analysis; Linear Models; Losartan; Male; Middle Aged; Ramipril; Treatment Outcome	2011
Renin-angiotensin system inhibitors reduce the progression of mesangioproliferative glomerulonephritis: 10 year follow-up. European journal of internal medicine, 2011, Volume: 22, Issue:6 Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biopsy; Disease Progression; Evidence-Based Medicine; Follow-Up Studies; Glomerular Filtration Rate; Glomerulonephritis, Membranoproliferative; Humans; Losartan; Prospective Studies; Proteinuria; Ramipril; Renin-Angiotensin System; Treatment Outcome; Young Adult	2011
[Possibilities of rational combination antihypertensive therapy: results of HEMERA international clinical trial]. Terapevticheskii arkhiv, 2013, Volume: 85, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Blood Pressure; Diuretics; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Prospective Studies; Ramipril; Treatment Outcome; Young Adult	2013
Combination therapy with aliskiren versus ramipril or losartan added to conventional therapy in patients with type 2 diabetes mellitus, uncontrolled hypertension and microalbuminuria. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2015, Volume: 16, Issue:4 Topics: Aged; Albuminuria; Amides; Blood Pressure; Creatinine; Diabetes Mellitus, Type 2; Diastole; Drug Therapy, Combination; Female; Fumarates; Humans; Hypertension; Losartan; Male; Potassium; Ramipril; Systole	2015
Ramipril and Losartan Exert a Similar Long-Term Effect upon Markers of Heart Failure, Endogenous Fibrinolysis, and Platelet Aggregation in Survivors of ST-Elevation Myocardial Infarction: A Single Centre Randomized Trial. BioMed research international, 2016, Volume: 2016 Topics: Aged; Biomarkers; Cardiovascular Agents; Fibrinolysis; Heart Failure; Humans; Losartan; Middle Aged; Myocardial Infarction; Platelet Aggregation; Ramipril	2016

Other Studies

76 other study(ies) available for losartan and ramipril

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Lipophilicity of acidic compounds: impact of ion pair partitioning on drug design. Bioorganic & medicinal chemistry letters, 2011, Jun-15, Volume: 21, Issue:12 Topics: Acids; Albumins; Drug Design; Humans; Hydrogen-Ion Concentration; Lipids; Molecular Structure; Pharmaceutical Preparations; Protein Binding	2011
Kinins mediate the antiproliferative effect of ramipril in rat carotid artery. Biochemical and biophysical research communications, 1992, Jan-15, Volume: 182, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Bradykinin; Bridged Bicyclo Compounds; Carotid Arteries; Carotid Artery Injuries; Endothelium, Vascular; Imidazoles; Kinins; Losartan; Male; Muscle, Smooth, Vascular; Oligopeptides; Ramipril; Rats; Rats, Inbred Strains; Tetrazoles	1992
Kinins, nitric oxide, and the hypotensive effect of captopril and ramiprilat in hypertension. Hypertension (Dallas, Tex. : 1979), 1992, Volume: 19, Issue:2 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arginine; Biphenyl Compounds; Blood Pressure; Captopril; Hypertension; Imidazoles; Kinins; Losartan; Male; Nitric Oxide; omega-N-Methylarginine; Pyrroles; Ramipril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles	1992
Role of angiotensin II receptor antagonism and converting enzyme inhibition in the progression and regression of cardiac hypertrophy in rats. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1991, Volume: 9, Issue:6 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Abdominal; Biphenyl Compounds; Bridged Bicyclo Compounds; Cardiomegaly; Constriction; Hypertension; Imidazoles; Losartan; Male; Ramipril; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Tetrazoles	1991
Role of angiotensin in pressure overload-induced hypertrophy in rats: effects of angiotensin-converting enzyme inhibitors, an AT1 receptor antagonist, and surgical reversal. Journal of cardiovascular pharmacology, 1994, Volume: 23, Issue:2 Topics: Angiotensin I; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Abdominal; Biphenyl Compounds; Blood Pressure; Body Weight; Cardiomegaly; Enalapril; Heart Ventricles; Imidazoles; Losartan; Male; Organ Size; Ramipril; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Tetrazoles; Ventricular Function	1994
The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors. The Annals of thoracic surgery, 1995, Volume: 60, Issue:3 Topics: Adrenergic beta-Antagonists; Amino Acid Oxidoreductases; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Biphenyl Compounds; Bradykinin; Bradykinin Receptor Antagonists; Heart; Imidazoles; Losartan; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rabbits; Ramipril; Receptors, Angiotensin; Receptors, Bradykinin; Tetrazoles	1995
Nitric oxide and prostaglandins in the prolonged effects of losartan and ramipril in hypertension. Hypertension (Dallas, Tex. : 1979), 1995, Volume: 26, Issue:2 Topics: Animals; Antihypertensive Agents; Arginine; Biphenyl Compounds; Blood Pressure; Bradykinin; Drug Interactions; Hypertension; Imidazoles; Indomethacin; Kidney Function Tests; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Prostaglandins; Ramipril; Rats; Rats, Inbred SHR; Tetrazoles	1995
Tonic stimulation of renin gene expression by nitric oxide is counteracted by tonic inhibition through angiotensin II. Proceedings of the National Academy of Sciences of the United States of America, 1995, Aug-15, Volume: 92, Issue:17 Topics: Analysis of Variance; Angiotensin II; Animals; Arginine; Biphenyl Compounds; Enzyme Precursors; Enzyme Repression; Gene Expression Regulation, Enzymologic; Imidazoles; Indomethacin; Kidney; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Ramipril; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Tetrazoles	1995
Contribution by bradykinin to the natriuretic response to the angiotensin converting enzyme inhibitor ramiprilat in spontaneously hypertensive rats. Naunyn-Schmiedeberg's archives of pharmacology, 1994, Volume: 350, Issue:1 Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Bradykinin; Glomerular Filtration Rate; Hemodynamics; Imidazoles; Losartan; Male; Natriuresis; Ramipril; Rats; Rats, Inbred SHR; Sodium; Tetrazoles	1994
Comparison of renal hemodynamic effect of ramiprilat to captopril; possible role of kinins. The Journal of pharmacology and experimental therapeutics, 1994, Volume: 270, Issue:2 Topics: Animals; Biphenyl Compounds; Blood Pressure; Bradykinin; Captopril; Imidazoles; Kidney; Kinins; Losartan; Male; Rabbits; Ramipril; Renal Circulation; Tetrazoles	1994
Angiotensin II increases norepinephrine release from atria by acting on angiotensin subtype 1 receptors. Hypertension (Dallas, Tex. : 1979), 1993, Volume: 22, Issue:5 Topics: Analysis of Variance; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Dose-Response Relationship, Drug; Guinea Pigs; Heart; Heart Atria; Imidazoles; In Vitro Techniques; Kinetics; Losartan; Male; Myocardium; Norepinephrine; Ramipril; Receptors, Angiotensin; Tetrazoles	1993
Mechanical strain and collagen potentiate mitogenic activity of angiotensin II in rat vascular smooth muscle cells. The Journal of clinical investigation, 1993, Volume: 92, Issue:6 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Biphenyl Compounds; Cell Division; Cells, Cultured; Collagen; DNA; Drug Synergism; Fibronectins; Gelatin; Imidazoles; Losartan; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Ramipril; Rats; Recombinant Proteins; Stress, Mechanical; Tetrazoles; Thymidine	1993
Reduction of myocardial infarct size by ramiprilat is independent of angiotensin II synthesis inhibition. European journal of pharmacology, 1993, Apr-06, Volume: 234, Issue:2-3 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Electrophysiology; Female; Hemodynamics; Imidazoles; Losartan; Male; Myocardial Infarction; Myocardial Ischemia; Rabbits; Ramipril; Tetrazoles	1993
Ramipril-induced decrease in renal lithium excretion in the rat. British journal of pharmacology, 1995, Volume: 116, Issue:4 Topics: Angiotensin I; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biphenyl Compounds; Blood Pressure; Creatinine; Imidazoles; Indomethacin; Kidney; Lithium; Losartan; Male; Ramipril; Rats; Rats, Wistar; Tetrazoles	1995
Nitric oxide and the depressor response to angiotensin blockade in hypertension. Hypertension (Dallas, Tex. : 1979), 1996, Volume: 27, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Coarctation; Arginine; Biphenyl Compounds; Blood Pressure; Hypertension; Imidazoles; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Ramipril; Rats; Rats, Sprague-Dawley; Renin; Tetrazoles; Vasoconstrictor Agents	1996
Chronic kinin blockade and effect of ramipril in renal adaptation to sodium restriction. Hypertension (Dallas, Tex. : 1979), 1996, Volume: 27, Issue:1 Topics: Adaptation, Physiological; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Diet, Sodium-Restricted; Electrolytes; Hemodynamics; Imidazoles; Kidney; Losartan; Male; Ramipril; Rats; Rats, Sprague-Dawley; Renal Circulation; Renin-Angiotensin System; Tetrazoles; Time Factors	1996
Regulation of ANG II receptor in hypertension: role of ANG II. The American journal of physiology, 1996, Volume: 271, Issue:1 Pt 2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Gene Expression; Hypertension; Imidazoles; Losartan; Male; Nephrectomy; Ramipril; Rats; Rats, Wistar; Receptors, Angiotensin; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta	1996
Pressor action of angiotensin I at the ventrolateral medulla: effect of selective angiotensin blockade. Immunopharmacology, 1996, Volume: 33, Issue:1-3 Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Imidazoles; Losartan; Male; Medulla Oblongata; Microinjections; Peptide Fragments; Ramipril; Rats; Rats, Wistar; Receptors, Angiotensin; Tetrazoles	1996
Threshold sodium excretory and renal blood flow effects of angiotensin converting enzyme inhibition. Journal of hypertension, 1995, Volume: 13, Issue:12 Pt 1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Differential Threshold; Diuresis; Hemodynamics; Imidazoles; Losartan; Natriuresis; Nephrectomy; Potassium; Ramipril; Rats; Rats, Wistar; Renal Circulation; Tetrazoles; Vasodilation	1995
Blockade of bradykinin B2 receptors prevents the increase in capillary density induced by chronic angiotensin-converting enzyme inhibitor treatment in stroke-prone spontaneously hypertensive rats. Hypertension (Dallas, Tex. : 1979), 1997, Volume: 29, Issue:1 Pt 2 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Bradykinin; Bradykinin Receptor Antagonists; Capillaries; Coronary Vessels; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Losartan; Male; Neovascularization, Pathologic; Ramipril; Rats; Rats, Inbred SHR; Receptor, Bradykinin B2; Tetrazoles	1997
Functional evidence that the central renin-angiotensin system plays a role in the pressor response induced by central injection of carbachol. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 1997, Volume: 30, Issue:4 Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Carbachol; Cerebral Ventricles; Cholinergic Agonists; Losartan; Male; Pressoreceptors; Ramipril; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System	1997
Ramipril prevents endothelial dysfunction induced by oxidized low-density lipoproteins: a bradykinin-dependent mechanism. Hypertension (Dallas, Tex. : 1979), 1997, Volume: 30, Issue:3 Pt 1 Topics: Acetylcholine; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Endothelium, Vascular; Guanylate Cyclase; Lipoproteins, LDL; Losartan; Male; Nitric Oxide; Ramipril; Rats; Rats, Wistar; Vasodilation	1997
Bradykinin may be involved in neuropeptide Y-induced diuresis, natriuresis, and calciuresis. The American journal of physiology, 1998, Volume: 275, Issue:4 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Bradykinin Receptor Antagonists; Calcium; Creatinine; Denervation; Diuresis; Infusions, Intravenous; Kidney; Losartan; Male; Natriuresis; Neuropeptide Y; Ramipril; Rats; Rats, Wistar; Receptor, Bradykinin B2; Regional Blood Flow; Renal Circulation; Vascular Resistance	1998
Effects of candesartan on the renin system in conscious rats. Journal of the American Society of Nephrology : JASN, 1999, Volume: 10 Suppl 11 Topics: Adrenal Glands; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Losartan; Male; Ramipril; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin; Renin-Angiotensin System; RNA, Messenger; Tetrazoles	1999
Interaction between the renin-angiotensin system and insulin-like growth factor I in aorto-caval fistula-induced cardiac hypertrophy in rats. Acta physiologica Scandinavica, 1999, Volume: 165, Issue:2 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta, Abdominal; Aortic Diseases; Arteriovenous Fistula; Cardiomegaly; Disease Models, Animal; Follow-Up Studies; Hemodynamics; Insulin-Like Growth Factor I; Losartan; Male; Myocardium; Pilot Projects; Ramipril; Rats; Rats, Wistar; Receptor, IGF Type 1; Renin-Angiotensin System; RNA, Messenger; Vena Cava, Inferior	1999
Central vasopressin is modulated by chronic blockade of the renin-angiotensin system in experimental left ventricular hypertrophy. American journal of hypertension, 1999, Volume: 12, Issue:3 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Brain Chemistry; Hypertrophy, Left Ventricular; Losartan; Ramipril; Rats; Rats, Wistar; Renin-Angiotensin System; Vasopressins	1999
Absence of nitrate tolerance after long-term treatment with ramipril: an endothelium-dependent mechanism. Journal of cardiovascular pharmacology, 1999, Volume: 34, Issue:4 Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta, Thoracic; Bradykinin; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Endothelium, Vascular; In Vitro Techniques; Losartan; Male; Nitrates; Nitric Oxide Synthase; Nitroglycerin; omega-N-Methylarginine; Ramipril; Rats; Rats, Wistar; Superoxides; Time Factors; Vasodilator Agents	1999
Renin-angiotensin system inhibitors as antihypertrophic agents. Die Pharmazie, 2000, Volume: 55, Issue:8 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Kidney; Kidney Diseases; Losartan; Nephrectomy; Ramipril; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System	2000
Intrarenal renin-angiotensin system contributes to tubular acidification adaptation following uninephrectomy. Experimental nephrology, 2001, Volume: 9, Issue:1 Topics: Acids; Adaptation, Physiological; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Kidney; Kidney Tubules, Proximal; Losartan; Male; Nephrectomy; Postoperative Period; Ramipril; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System	2001
Renal and vascular injury induced by exogenous angiotensin II is AT1 receptor-dependent. Nephron, 2001, Volume: 87, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Carotid Artery Injuries; Catheterization; Kidney Diseases; Losartan; Male; Peptidyl-Dipeptidase A; Ramipril; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Vasoconstrictor Agents	2001
Combined angiotensin converting enzyme inhibition and angiotensin AT(1) receptor blockade up-regulates myocardial AT(2) receptors in remodeled myocardium post-infarction. Cardiovascular research, 2001, Volume: 51, Issue:1 Topics: Analysis of Variance; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Drug Therapy, Combination; Female; Imidazoles; Losartan; Models, Animal; Myocardial Infarction; Myocardium; Pyridines; Radioligand Assay; Ramipril; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Regression Analysis; Sheep; Ventricular Remodeling	2001
Combined angiotensin II receptor antagonism and angiotensin-converting enzyme inhibition further attenuates postinfarction left ventricular remodeling. Circulation, 2001, Jun-12, Volume: 103, Issue:23 Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Electrocardiography; Female; Image Processing, Computer-Assisted; Losartan; Magnetic Resonance Imaging, Cine; Myocardial Infarction; Myocardium; Ramipril; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sheep; Stroke Volume; Systole; Ventricular Function, Left; Ventricular Remodeling	2001
Impaired angiotensin II regulation of renal C-type natriuretic peptide mRNA expression in experimental diabetes mellitus. Cardiovascular research, 2001, Aug-15, Volume: 51, Issue:3 Topics: Angiotensin II; Animals; Blotting, Northern; Diabetes Mellitus, Experimental; Gene Expression Regulation; Kidney Cortex; Losartan; Male; Natriuretic Peptide, C-Type; Ramipril; Rats; Rats, Wistar; Renin-Angiotensin System; RNA, Messenger	2001
Cardioprotective effects of ramipril and losartan in right ventricular pressure overload in the rabbit: importance of kinins and influence on angiotensin II type 1 receptor signaling pathway. Circulation, 2001, Aug-21, Volume: 104, Issue:8 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin Receptor Antagonists; Disease Models, Animal; Dose-Response Relationship, Drug; Electric Stimulation; GTP-Binding Proteins; Hemodynamics; In Vitro Techniques; Kinins; Losartan; Male; Myocardial Contraction; Myocardium; Organ Size; Papillary Muscles; Protein Subunits; Pulmonary Artery; Rabbits; Ramipril; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Signal Transduction; Ventricular Dysfunction, Right	2001
Angiotensin AT(1) receptor signalling modulates reparative angiogenesis induced by limb ischaemia. British journal of pharmacology, 2002, Volume: 135, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Extremities; Femoral Artery; Gene Expression; Ischemia; Losartan; Male; Mice; Neovascularization, Physiologic; Peptidyl-Dipeptidase A; Ramipril; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Receptors, Angiotensin; Receptors, Bradykinin; Renin-Angiotensin System; RNA, Messenger; Signal Transduction	2002
Who is fooling us? Lancet (London, England), 2002, Jul-06, Volume: 360, Issue:9326 Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Losartan; Ramipril; Risk Factors	2002
Best bang for the buck? Current hypertension reports, 2003, Volume: 5, Issue:1 Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Ramipril; Randomized Controlled Trials as Topic; Risk Factors; Stroke	2003
Vasopeptidase inhibitor omapatrilat induces profound insulin sensitization and increases myocardial glucose uptake in Zucker fatty rats: Studies comparing a vasopeptidase inhibitor, angiotensin-converting enzyme inhibitor, and angiotensin II type I recept Circulation, 2003, Apr-15, Volume: 107, Issue:14 Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biological Transport; Blood Glucose; Bradykinin; Bradykinin Receptor Antagonists; Drug Synergism; Enzyme Inhibitors; Glucose; Glucose Clamp Technique; Insulin; Insulin Resistance; Losartan; Male; Myocardium; Neprilysin; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Protease Inhibitors; Pyridines; Ramipril; Rats; Rats, Zucker; Receptor, Angiotensin, Type 1; Receptor, Bradykinin B2; Thiazepines	2003
Angiotensin II and the fibroproliferative response to acute lung injury. American journal of physiology. Lung cellular and molecular physiology, 2004, Volume: 286, Issue:1 Topics: Acute Disease; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antibiotics, Antineoplastic; Antihypertensive Agents; Bleomycin; Cell Division; Cells, Cultured; Collagen; Fibroblasts; Humans; Losartan; Lung; Peptidyl-Dipeptidase A; Procollagen; Pulmonary Fibrosis; Ramipril; Renin-Angiotensin System; Transforming Growth Factor beta	2004
Adding angiotensin II type 1 receptor blockade to angiotensin-converting enzyme inhibition limits myocyte remodeling after myocardial infarction. Journal of cardiac failure, 2003, Volume: 9, Issue:3 Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Female; Losartan; Myocardial Infarction; Myocardium; Ramipril; Sheep; Ventricular Remodeling	2003
Angiotensin II-dependent increased expression of Na+-glucose cotransporter in hypertension. American journal of physiology. Renal physiology, 2004, Volume: 286, Issue:1 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Cell Membrane; Gene Expression; Glucose; Hypertension, Renal; Immunoblotting; Kidney Cortex; Losartan; Male; Monosaccharide Transport Proteins; Ramipril; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; RNA, Messenger; Sodium; Sodium-Glucose Transporter 2	2004
Angiotensin-converting enzyme inhibitors and stroke prevention: what about the influence of atrial fibrillation and antithrombotic therapy? Stroke, 2003, Volume: 34, Issue:11 Topics: Angiotensin-Converting Enzyme Inhibitors; Atenolol; Atrial Fibrillation; Clinical Trials as Topic; Fibrinolytic Agents; Humans; Losartan; Ramipril; Stroke	2003
Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone. Circulation, 2004, May-11, Volume: 109, Issue:18 Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Diseases; Apolipoproteins E; Arteriosclerosis; Cell Line; Enzyme Induction; Eplerenone; Hormone Antagonists; Humans; Lipid Peroxidation; Lipoproteins, LDL; Losartan; Macrophages, Peritoneal; Membrane Proteins; Mice; Mice, Knockout; Mineralocorticoid Receptor Antagonists; NADPH Oxidases; Oxidative Stress; Peptidyl-Dipeptidase A; Phosphoproteins; Protein Transport; Ramipril; Receptor, Angiotensin, Type 1; Receptors, Mineralocorticoid; RNA, Messenger; Spironolactone; Superoxides	2004
Angiotensin II-dependent induction of AT(2) receptor expression after renal ablation. American journal of physiology. Renal physiology, 2005, Volume: 288, Issue:1 Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Blood Pressure; Diuresis; Gene Expression Regulation; Imidazoles; Kidney; Ligation; Losartan; Male; Nephrectomy; Proteinuria; Pyridines; Ramipril; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Renal Artery; RNA, Messenger	2005
ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-kappaB activity and AT1 receptor expression. Biochemical and biophysical research communications, 2004, Dec-10, Volume: 325, Issue:2 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Cell Line; Chemokine CCL2; Chemokines; Down-Regulation; Drug Interactions; Endothelium, Vascular; Humans; Imidazoles; Interleukin-8; Losartan; Monocytes; NF-kappa B; Peptidyl-Dipeptidase A; Pyridines; Ramipril; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Simvastatin; Umbilical Veins	2004
Losartan-ramipril combination treatment. The Journal of the Association of Physicians of India, 2004, Volume: 52 Topics: Antihypertensive Agents; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Heart Rate; Humans; Hypertension; Losartan; Ramipril	2004
Late recurrence of scleroderma renal crisis in a renal transplant recipient despite angiotensin II blockade. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2005, Volume: 45, Issue:5 Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arterioles; Basement Membrane; Female; Humans; Hypertension, Renal; Immunosuppression Therapy; Kidney Diseases; Kidney Failure, Chronic; Kidney Glomerulus; Kidney Transplantation; Losartan; Postoperative Complications; Ramipril; Recurrence; Renal Artery; Scleroderma, Diffuse	2005
[Effects of losartan, ramipril and their combination on left ventricular remodeling and function in spontaneous hypertensive rats]. Zhonghua yi xue za zhi, 2005, Nov-30, Volume: 85, Issue:45 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Blotting, Western; Calcium Channels, L-Type; Calcium-Transporting ATPases; Drug Therapy, Combination; Female; Hypertension; Losartan; Male; Ramipril; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Ventricular Dysfunction, Left; Ventricular Remodeling	2005
Angiotensin inhibition or blockade for the treatment of patients with quiescent lupus nephritis and persistent proteinuria. Lupus, 2005, Volume: 14, Issue:12 Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Creatinine; Enalapril; Female; Follow-Up Studies; Humans; Losartan; Lupus Nephritis; Male; Proteinuria; Ramipril; Retrospective Studies; Serum Albumin	2005
Role of angiotensin II in retinal leukostasis in the diabetic rat. Experimental eye research, 2006, Volume: 83, Issue:5 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Concanavalin A; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Intercellular Adhesion Molecule-1; Leukocyte Common Antigens; Leukostasis; Losartan; Male; Nifedipine; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Ramipril; Rats; Rats, Long-Evans; Retina; Retinal Diseases	2006
Effects of angiotensin II on connexin 43 of VSMCs in arteriosclerosis. Journal of Zhejiang University. Science. B, 2006, Volume: 7, Issue:8 Topics: Angiotensin II; Animals; Arteriosclerosis; Body Weight; Cholesterol; Connexin 43; Losartan; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Rabbits; Ramipril; RNA, Messenger	2006
Antihypertensive agents have different ability to modulate arterial pressure and heart rate variability in 2K1C rats. American journal of hypertension, 2006, Volume: 19, Issue:10 Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atenolol; Autonomic Nervous System; Blood Pressure; Cardiovascular System; Heart Rate; Hydrochlorothiazide; Hypertension; Losartan; Male; Ramipril; Rats; Rats, Wistar; Sympathetic Nervous System	2006
Inhibition of renin angiotensin system decreases renal protein oxidative damage in diabetic rats. Biochemical and biophysical research communications, 2008, Apr-11, Volume: 368, Issue:3 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetic Nephropathies; Glycation End Products, Advanced; Heterocyclic Compounds, 3-Ring; Kidney; Losartan; Oxidative Stress; Protease Inhibitors; Proteins; Ramipril; Rats; Rats, Zucker; Renin-Angiotensin System	2008
Antidepressant activity of fosinopril, ramipril and losartan, but not of lisinopril in depressive paradigms of albino rats and mice. Indian journal of experimental biology, 2008, Volume: 46, Issue:3 Topics: Amitriptyline; Analysis of Variance; Animals; Antidepressive Agents; Antihypertensive Agents; Fosinopril; Lisinopril; Long-Term Synaptic Depression; Losartan; Male; Mice; Motor Activity; Ramipril; Rats; Rats, Wistar	2008
Renin-angiotensin system blockade is effective in reducing proteinuria of patients with progressive nephropathy caused by MYH9 mutations (Fechtner-Epstein syndrome). Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2008, Volume: 23, Issue:8 Topics: Adolescent; Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cataract; Female; Hearing Loss, Sensorineural; Humans; Kidney Diseases; Losartan; Male; Molecular Motor Proteins; Mutation; Myosin Heavy Chains; Proteinuria; Ramipril; Renin-Angiotensin System; Syndrome; Telmisartan; Thrombocytopenia	2008
[A 60-year-old man with heart failure, dry cough and elevated INR values]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2008, Aug-14, Volume: 128, Issue:15 Topics: Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aryl Hydrocarbon Hydroxylases; Coronary Thrombosis; Cough; Cytochrome P-450 CYP2C9; Genotype; Heart Failure; Humans; International Normalized Ratio; Losartan; Male; Middle Aged; Pharmacogenetics; Polypharmacy; Ramipril; Warfarin	2008
Sirolimus and everolimus reduce albumin endocytosis in proximal tubule cells via an angiotensin II-dependent pathway. Transplant immunology, 2010, Volume: 23, Issue:3 Topics: Albumins; Angiotensin II; Cell Line; Down-Regulation; Drug Therapy, Combination; Endocytosis; Epithelial Cells; Everolimus; Humans; Immunosuppressive Agents; Kidney Tubules, Proximal; Losartan; Low Density Lipoprotein Receptor-Related Protein-2; Ramipril; Receptor, Angiotensin, Type 1; Receptors, Cell Surface; Signal Transduction; Sirolimus	2010
Effects of commonly administered agents and genetics on nebivolol pharmacokinetics: drug-drug interaction studies. Journal of clinical pharmacology, 2011, Volume: 51, Issue:4 Topics: Adult; Antihypertensive Agents; Benzopyrans; Cytochrome P-450 CYP2D6; Digoxin; Drug Interactions; Ethanolamines; Female; Fluoxetine; Furosemide; Genotype; Humans; Hydrochlorothiazide; Losartan; Male; Middle Aged; Nebivolol; Ramipril; Warfarin; Young Adult	2011
Marfan syndrome and focal segmental glomerulosclerosis: a novel association. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2010, Volume: 21, Issue:4 Topics: Adolescent; Adrenal Cortex Hormones; Antihypertensive Agents; Fibrillins; Follow-Up Studies; Glomerulosclerosis, Focal Segmental; Humans; Losartan; Male; Marfan Syndrome; Microfilament Proteins; Ramipril	2010
Immobilization stress induces endothelial dysfunction by oxidative stress via the activation of the angiotensin II/its type I receptor pathway. Atherosclerosis, 2010, Volume: 213, Issue:1 Topics: Acetylcholine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Arteries; Atherosclerosis; Immobilization; Losartan; Male; Nitric Oxide Synthase Type III; Oxidative Stress; Ramipril; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin	2010
Comparison of the effects of losartan vs. ramipril on several adipocytokines and vascular remodeling biomarkers. Hypertension research : official journal of the Japanese Society of Hypertension, 2011, Volume: 34, Issue:1 Topics: Adipokines; Antihypertensive Agents; Biomarkers; Humans; Losartan; Ramipril	2011
Influence of ramiprilat and losartan on ischemia reperfusion injury in rat hearts. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2012, Volume: 13, Issue:1 Topics: Animals; Antihypertensive Agents; Arrhythmias, Cardiac; Drug Therapy, Combination; Heart; Heart Rate; Kaplan-Meier Estimate; Losartan; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Ramipril; Rats; Rats, Wistar	2012
Pierson syndrome in an adolescent girl with nephrotic range proteinuria but a normal GFR. Pediatric nephrology (Berlin, Germany), 2012, Volume: 27, Issue:5 Topics: Abnormalities, Multiple; Adolescent; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biopsy; Eye Abnormalities; Female; Glomerular Filtration Rate; Humans; Kidney; Laminin; Losartan; Mutation; Mutation, Missense; Myasthenic Syndromes, Congenital; Myopia; Nephrotic Syndrome; Phenotype; Proteinuria; Pupil Disorders; Ramipril; Retinal Detachment; Vision Disorders	2012
Expressional profile of cardiac uncoupling protein-2 following myocardial ischemia reperfusion in losartan- and ramiprilat-treated rats. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2014, Volume: 15, Issue:3 Topics: Animals; Blood Pressure; Gene Expression Profiling; Heart Rate; Hemodynamics; Ion Channels; Losartan; Male; Mitochondrial Proteins; Myocardial Reperfusion Injury; Ramipril; Rats, Wistar; RNA, Messenger; Transcription, Genetic; Uncoupling Protein 2	2014
Comparing individual angiotensin-converting enzyme inhibitors with losartan in the risk of hospitalization for pneumonia and related mortality: a nationwide cohort study. Journal of hypertension, 2015, Volume: 33, Issue:3 Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cohort Studies; Enalapril; Female; Hospitalization; Humans; Incidence; Losartan; Male; Middle Aged; Pneumonia; Ramipril; Risk; Taiwan	2015
The Association of Losartan and Ramipril Therapy With Kidney and Cardiovascular Outcomes in Patients With Chronic Kidney Disease: A Chinese Nation-Wide Cohort Study in Taiwan. Medicine, 2015, Volume: 94, Issue:48 Topics: Adolescent; Adult; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Cohort Studies; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Hospitalization; Humans; Hypertension; Losartan; Male; Middle Aged; Proportional Hazards Models; Ramipril; Renal Insufficiency, Chronic; Taiwan; Young Adult	2015
Novel method to assess arterial insufficiency in rodent hind limb. The Journal of surgical research, 2016, Volume: 201, Issue:1 Topics: Animals; Feasibility Studies; Femoral Artery; Femoral Vein; Hindlimb; Hyperemia; Ligation; Losartan; Male; Muscle Contraction; Peripheral Arterial Disease; Ramipril; Rats, Inbred WKY; Ultrasonography	2016
Effects of renin-angiotensin system inhibitors on fibrosis in patients with alcoholic chronic pancreatitis. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2016, Volume: 67, Issue:1 Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Female; Humans; Liver Cirrhosis; Losartan; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Middle Aged; Pancreatitis, Chronic; Ramipril; Renin-Angiotensin System; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2	2016
Protective effect of losartan and ramipril against stress induced insulin resistance and related complications: Anti-inflammatory mechanisms. European journal of pharmacology, 2017, Apr-15, Volume: 801 Topics: Animals; Anti-Inflammatory Agents; Biomarkers; Insulin Resistance; Losartan; Male; Mice; Ramipril; Renin-Angiotensin System; Stress, Psychological	2017
The effects of single and combined application of ramipril and losartan on renal structure and function in hypertensive rats. Clinical and experimental hypertension (New York, N.Y. : 1993), 2018, Volume: 40, Issue:7 Topics: Albuminuria; Animals; Antihypertensive Agents; Collagen; Drug Therapy, Combination; Female; Hypertension; Kidney Glomerulus; Kidney Tubules; Losartan; Male; Microscopy; Organ Size; Ramipril; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY	2018
RAAS inhibitors directly reduce diabetes-induced renal fibrosis via growth factor inhibition. The Journal of physiology, 2019, Volume: 597, Issue:1 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Line; Connective Tissue Growth Factor; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Epithelial Cells; Eplerenone; Fibroblasts; Fibrosis; Humans; Kidney; Losartan; Male; Mannitol; Mineralocorticoid Receptor Antagonists; Proto-Oncogene Proteins c-sis; Ramipril; Rats, Wistar; Renin-Angiotensin System; Spironolactone	2019
A Comparative Study on the Memory-Enhancing Actions of Oral Renin-Angiotensin System Altering Drugs in Scopolamine-Treated Mice. American journal of Alzheimer's disease and other dementias, 2019, Volume: 34, Issue:5 Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Humans; Losartan; Male; Maze Learning; Memory Disorders; Memory, Long-Term; Memory, Short-Term; Mice; Muscarinic Antagonists; Ramipril; Renin-Angiotensin System; Scopolamine; Spatial Memory	2019
The effect of topical ramipril and losartan cream in inhibiting scar formation. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 118 Topics: Administration, Topical; Animals; Cicatrix; Fibroblasts; Losartan; Male; Mice, Inbred C57BL; Ramipril; Skin Cream; Smad3 Protein; Swine; Transforming Growth Factor beta1	2019
Angiotensin-converting enzyme inhibitors, angiotensin-II-receptor antagonists and angiotensin-receptor blocker/neprilysin inhibitor utilization in heart failure patients: Sub-analysis of a nation-wide population-based study in the Czech Republic. Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 2022, Volume: 166, Issue:3 Topics: Angiotensin II Type 2 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Antihypertensive Agents; Czech Republic; Heart Failure; Humans; Losartan; Neprilysin; Perindopril; Ramipril; Retrospective Studies; Telmisartan; Valsartan	2022